SMTL ID : 3qrj.2 (2 other biounits)

The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.82 Å

Oligo State

monomer

Ligands

1 x 919: 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide(Non-covalent)

919.1: 19 residues within 4Å: Chain A: L.26, V.34, A.47, K.49, E.60, E.64, M.68, I.71, V.77, I.93, E.94, F.95, M.96, G.99, H.139, L.148, A.158, D.159, F.160 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:E.64, A:E.64, A:I.71, A:V.77, A:I.93, A:L.148, A:A.158, A:D.159, A:F.160 Hydrogen bonds: A:E.64, A:E.64, A:E.64, A:M.96, A:M.96, A:D.159

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chan, W.W. et al., Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036. Cancer Cell (2011)

Release Date

2011-06-01

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence